COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality

The coronavirus disease 2019 (COVID‐19) pandemic necessitated down‐scaling of in‐hospital care to prohibit the spread of severe acute respiratory syndrome–coronavirus‐2. We (1) assessed patient perceptions on quality of care by telesurvey (cohort 1) and written questionnaire (cohort 2), and (2) analyzed trends in elective and nonelective admissions before (December 2019 to February 2020) and during (March to May 2020) the COVID‐19 pandemic in Austria. A total of 279 outpatients were recruited into cohort 1 and 138 patients into cohort 2. All admissions from December 2019 to May 2020 to the Division of Gastroenterology/Hepatology at the Vienna General Hospital were analyzed. A total of 32.6% (n = 91 of 279) of cohort 1 and 72.5% (n = 95 of 131) of cohort 2 had telemedical contact, whereas 59.5% (n = 166 of 279) and 68.2% (n = 90 of 132) had face‐to‐face visits. A total of 24.1% (n = 32 of 133) needed acute medical help during health care restrictions; however, 57.3% (n = 51 of 89) reported that contacting their physician during COVID‐19 was difficult or impossible. Patient‐reported satisfaction with treatment decreased significantly during restrictions in cohort 1 (visual analog scale [VAS] 0‐10: 9.0 ± 1.6 to 8.6 ± 2.2; P < 0.001) and insignificantly in cohort 2 (VAS 0‐10: 8.9 ± 1.6 to 8.7 ± 2.1; P = 0.182). Despite fewer hospital admissions during COVID‐19, the proportion of nonelective admissions (+6.3%) and intensive care unit admissions (+6.7%) increased. Patients with cirrhosis with nonelective admissions during COVID‐19 had significantly higher Model for End‐Stage Liver Disease (MELD) (25.5 [14.2] vs. 17.0 [interquartile range: 8.8]; P = 0.003) and ΔMELD (difference from last MELD: 3.9 ± 6.3 vs. 8.7 ± 6.4; P = 0.008), required immediate intensive care more frequently (26.7% vs. 5.6%; P = 0.034), and had significantly increased 30‐day liver‐related mortality (30.0% vs. 8.3%; P = 0.028). Conclusion: The COVID‐19 pandemic’s effects on quality of liver care is evident from decreased patient satisfaction, hospitalization of sicker patients with advanced chronic liver disease, and increased liver‐related mortality. Strategies for improved telemedical liver care and preemptive treatment of cirrhosis‐related complications are needed to counteract the COVID‐19‐associated restrictions of in‐hospital care.

[1]  N. Gunaratnam,et al.  Gastroenterologists and Patients Report High Satisfaction Rates With Telehealth Services During the Novel Coronavirus 2019 Pandemic , 2020, Clinical Gastroenterology and Hepatology.

[2]  T. Şahin,et al.  COVID-19 pandemic: Its impact on liver disease and liver transplantation , 2020, World journal of gastroenterology.

[3]  J. Pawlotsky.  COVID-19 and the liver-related deaths to come , 2020, Nature Reviews Gastroenterology & Hepatology.

[4]  Yuan Zhang,et al.  Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis , 2020, The Lancet.

[5]  Feng Gao,et al.  Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients. , 2020, Journal of gastroenterology and hepatology.

[6]  R. de Caterina,et al.  Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era , 2020, European heart journal.

[7]  M. Trauner,et al.  Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series , 2020, Annals of Internal Medicine.

[8]  Fang Lin,et al.  SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19 , 2020, Journal of Hepatology.

[9]  J. Alqahtani,et al.  Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis , 2020, Tropical medicine and infectious disease.

[10]  R. Fontana,et al.  Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement , 2020, Hepatology.

[11]  E. Tapper,et al.  The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care , 2020, Journal of Hepatology.

[12]  D. Segev,et al.  Early impact of COVID-19 on transplant center practices and policies in the United States , 2020, American Journal of Transplantation.

[13]  L. Mao,et al.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.

[14]  G. Lau,et al.  Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation , 2020, Hepatology International.

[15]  M. Serper,et al.  Telemedicine in Liver Disease and Beyond: Can the COVID‐19 Crisis Lead to Action? , 2020, Hepatology.

[16]  G. Tisone,et al.  The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs , 2020, American Journal of Transplantation.

[17]  T. Berg,et al.  Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper , 2020, JHEP Reports.

[18]  Heng Li,et al.  Coronavirus disease 2019 (COVID-19): current status and future perspectives , 2020, International Journal of Antimicrobial Agents.

[19]  W. Ko,et al.  Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status , 2020, International Journal of Antimicrobial Agents.

[20]  Subrata Ghosh,et al.  Implications of COVID-19 for patients with pre-existing digestive diseases , 2020, The Lancet Gastroenterology & Hepatology.

[21]  Yunpeng Ji,et al.  Potential association between COVID-19 mortality and health-care resource availability , 2020, The Lancet Global Health.

[22]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[23]  J. Bajaj,et al.  Use of Telehealth Expedites Evaluation and Listing of Patients Referred for Liver Transplantation. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  M. Trauner,et al.  Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy , 2019, Hepatology.

[25]  T. Reiberger,et al.  Elastography-based screening for esophageal varices in patients with advanced chronic liver disease , 2019, World journal of gastroenterology.

[26]  M. Trauner,et al.  Management of portal hypertension before and after liver transplantation , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[27]  H. Tilg,et al.  Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III) , 2017, Wiener klinische Wochenschrift.

[28]  A. Rahmel,et al.  Impact of dynamic changes in MELD score on survival after liver transplantation – a Eurotransplant registry analysis , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[29]  P. Schwabl,et al.  Advances in the management of HIV/HCV coinfection , 2016, Hepatology International.

[30]  R. Moreau,et al.  The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. , 2015, Journal of hepatology.

[31]  P. Thuluvath,et al.  Hyponatremia in cirrhosis: pathophysiology and management. , 2015, World journal of gastroenterology.

[32]  J. Talwalkar,et al.  Improving quality of health care for patients with cirrhosis. , 2014, Gastroenterology.

[33]  D. Gerber,et al.  Local access to subspecialty care influences the chance of receiving a liver transplant , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[34]  Paula Buchanan,et al.  The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. , 2012, Gastroenterology.

[35]  T. Therneau,et al.  Hyponatremia and mortality among patients on the liver-transplant waiting list. , 2008, The New England journal of medicine.

[36]  J. Bajaj,et al.  Telehealth‐Based Evaluation Identifies Patients Who Are Not Candidates for Liver Transplantation , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[37]  M. Trauner,et al.  Changes in HVPG predict hepatic decompensation in patients who achieved SVR to IFN-free therapy. , 2019, Hepatology.

[38]  R. de Franchis.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.